Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kluft

Showing results (151-160 of 230) with videos related to

Pageof 23
Sort By:
The Quarterly Journal of Medicine|January 1, 1986
The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozololJ J Belch, R Madhok, B McArdle, et al.
Atherosclerosis|February 13, 2001
Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectorisM P de Maat, J M Ossewaarde, P W Verheggen, et al.
Atherosclerosis|December 17, 2002
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitusM A van de Ree, M V Huisman, H M G Princen, et al.
Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.
Journal of the American College of Cardiology|September 1, 1995
Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damageA W Haider, F Andreotti, D R Hackett, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|April 1, 1984
Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained femalesI A Huisveld, C Kluft, A J Hospers, et al.
Thrombosis and Haemostasis|March 1, 1995
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PAJ L Heeremans, R Prevost, M E Bekkers, et al.
Thrombosis and Haemostasis|February 1, 1994
Differences in u-PA and t-PA increase during acute exercise: relation with exercise parametersP J van den Burg, G Dooijewaard, M van Vliet, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 31, 2001
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulantsM J Kemme, R A Faaij, R C Schoemaker, et al.
Blood|December 1, 1990
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation productsV W van Hinsbergh, K A Bauer, T Kooistra, et al.
Pageof 23

Showing results (151-160 of 230) with videos related to

Sort By:
Pageof 23
The Quarterly Journal of Medicine|January 1, 1986
The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozololJ J Belch, R Madhok, B McArdle, et al.
Atherosclerosis|February 13, 2001
Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectorisM P de Maat, J M Ossewaarde, P W Verheggen, et al.
Atherosclerosis|December 17, 2002
Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitusM A van de Ree, M V Huisman, H M G Princen, et al.
Contraception|January 12, 1999
Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolismL A Heinemann, A Assmann, M Spannagl, et al.
Journal of the American College of Cardiology|September 1, 1995
Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damageA W Haider, F Andreotti, D R Hackett, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|April 1, 1984
Effect of exercise and oral contraceptive agents on fibrinolytic potential in trained femalesI A Huisveld, C Kluft, A J Hospers, et al.
Thrombosis and Haemostasis|March 1, 1995
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PAJ L Heeremans, R Prevost, M E Bekkers, et al.
Thrombosis and Haemostasis|February 1, 1994
Differences in u-PA and t-PA increase during acute exercise: relation with exercise parametersP J van den Burg, G Dooijewaard, M van Vliet, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 31, 2001
Disagreement between bedside and laboratory activated partial thromboplastin time and international normalized ratio for various novel anticoagulantsM J Kemme, R A Faaij, R C Schoemaker, et al.
Blood|December 1, 1990
Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation productsV W van Hinsbergh, K A Bauer, T Kooistra, et al.
Pageof 23